Targeted Annihilation: The Science of Radioligand Therapy

toegevoegd een audio Sciences et Technologies

2026-02-11 15:04:35

The global Alpha-Emitter Radioligand Therapy (α-RLT) market is at the forefront of a paradigm shift in oncology. Unlike traditional beta-emitters (like Lutetium-177), alpha-emitters deliver high-energy radiation over a much shorter range—typically just a few cell diameters—allowing for devastating "double-strand breaks" in cancer DNA while significantly sparing...

0 Reacties 0 aandelen 4 Views 0 voorbeeld